Shire says willing to recommend Takeda’s $64 billion offer to shareholders
LONDON/NEW YORK (Reuters) – London-listed drugmaker Shire Plc said it was willing to recommend a deal with Takeda Pharmaceutical Co to its shareholders, after the Japanese company sweetened its acquisition offer to 46 billion pounds ($64 billion).